Results 201 to 210 of about 18,471 (244)

The Regulation and Function of Hippo/YAP Pathway in Cancer

The FASEB Journal, Volume 40, Issue 7, 15 April 2026.
Hippo/YAP pathway signaling plays critical roles in the progression of multiple cancer types. This review summarizes current knowledge of Hippo/YAP pathway regulation and function in cancer. We discuss the core components of the Hippo/YAP pathway; its crosstalk with other signaling pathways; regulation by non‐coding RNAs; roles of YAP signaling in ...
Chinmoy Ghosh, Ruchi Kakar, Seline Torkamboor, Yue Sun   +3 more
wiley   +1 more source

Design of a phase II randomised, double-blind, placebo-controlled, dose-finding trial of BI 1819479 in patients with idiopathic pulmonary fibrosis. [PDF]

ERJ Open Res
Wuyts WA, Bonella F, Ishii H, Lee JS, Renzoni E, Hadl S, Krzykalla J, Stowasser S, Engel M, Molina MM.   +9 more
europepmc   +1 more source

Identify GDPD3 as a key regulator of epithelial-mesenchymal transition and prostate adenocarcinoma progression via the LPA/LPAR1/AKT axis: transcriptomic and experimental study. [PDF]

Front Immunol
Hao L, Chen X, He T, Wu T, Wen Z, Ji Z, Zheng X, Zheng Q, Zhou Q, He C, Long Q, Sun D.   +11 more
europepmc   +1 more source

Recent Developments and Applications of Capillary and Microchip Electrophoresis in Proteomics and Peptidomics (2023-2025). [PDF]

J Sep Sci
Štěpánová S, Kašička V.
europepmc   +1 more source

Oxypeucedanin attenuates neuropathic pain in male mice via inhibiting lysophosphatidic acid receptor signaling. [PDF]

iScience
Li J, Tang W, Wang L, Gu Y, You W, Yang W, Huang Y, Yu X, Zhu R, Xu Y, Li J, Zhu Q.   +11 more
europepmc   +1 more source

Liraglutide attenuates aluminum chloride-induced Alzheimer's disease in rats by modulating the oxLDL/LPA/LPAR1 pathway. [PDF]

Commun Biol
Abo El-Magd NF, Ramadan NM, Eraky SM.
europepmc   +1 more source

Metabolic reprogramming of efferocytosis in the tumour microenvironment: From apoptotic-cell clearance to therapeutic targeting. [PDF]

Clin Transl Med
Yang Q, Yan J, Yang Q.
europepmc   +1 more source

Vasoprotective effects of lysophosphatidic acid inhibit vascular injury caused by SARS-CoV-2 infection. [PDF]

Sci Rep
Muramatsu F, Hosoe N, Suzuki T, Shimamura T, Hayashi Y, Takara K, Lynda L, Shimizu A, Jia W, Noda Y, Takakura N, Okamoto T, Kidoya H.   +12 more
europepmc   +1 more source

Pharmacological Blockade of LPAR1 Does Not Provide Neuroprotection in a Rat Model of Ocular Hypertensive Glaucoma. [PDF]

Transl Vis Sci Technol
Kocherlakota S, Nicol A, Locri F, Stebbins KJ, Lorrain DS, Tribble JR, Williams PA.   +6 more
europepmc   +1 more source

Lysophosphatidic acid selectively modulates excitatory transmission in hippocampal neurons. [PDF]

Cell Biosci
Brandt N, Battefeld A, Suckau O, Stadler K, Singh B, Zhang P, Aoki J, Chun J, Henneberger C, Grantyn R, Vogt J, Nitsch R, Strauss U, Bräuer AU.   +13 more
europepmc   +1 more source